TREVICTA 175 mg, 263 mg, 350 mg, 525 mg prolonged release suspension for injection

Home
Medicines
TREVICTA 175 mg, 263 mg, 350 mg, 525 mg prolonged release suspension for injection

Company:
Janssen Sciences Ireland (a Johnson & Johnson Company)
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
Paliperidone Palmitate
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/14/971/007

175 milligram(s)

N05AX,N05AX13

Prolonged-release suspension for injection

EU/1/14/971/008

263 milligram(s)

N05AX,N05AX13

Prolonged-release suspension for injection

EU/1/14/971/009

350 milligram(s)

N05AX,N05AX13

Prolonged-release suspension for injection

EU/1/14/971/010

525 milligram(s)

N05AX,N05AX13

Prolonged-release suspension for injection

Address:
Janssen Sciences Ireland UC, Barnahely, Ringaskiddy, IRL - Co. Cork P43 FA46
Medical Information E-mail:
medinfo@its.jnj.com
Telephone:
+353 1 4665200
Website:
https://innovativemedicine.jnj.com/ireland/
Medical Information Direct Line:
1800 709 122

Address: